Hello Chris and GP-UK,
On Wednesday, January 27, 2010, at 12:15:04 PM, Chris wrote:
> Sibutramine has lost its european license as the increased risk of stroke
> outweighs the benefits of minimal weight loss.
> Found out through my dispenser, an alert would have been nice.
MHRA (Medicines and Healthcare products Regulatory Agency) provide an
email and/or RSS 'alerting service'. An alert entitled "Sibutramine:
Suspension of marketing authorisation as risks outweigh benefits" was
generated on 21 January 2010 at 18:08:24.
The details on how to subscribe to the service appears to be somewhat
buried in their web site. At least, I just had some difficulty
locating it for this email (been subscribed for several years). Here
it is:
http://www.mhra.gov.uk/Onlineservices/General/E-mailalertingservice/index.htm
or
http://preview.tinyurl.com/y96y89v
--
Chris Salter mailto:[log in to unmask]
Lincolnshire Post-Polio Network http://www.lincolnshirepostpolio.org.uk/
Polio and Post-Polio News http://mt.lincolnshirepostpolio.org.uk/pandppnews/
|